ArticleBiomedicines2022

Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway.

Tekle Pauzaite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.